Ranbaxy Gets USFDA Approval For Doxycycline Tablets

by Medindia Content Team on  June 2, 2006 at 4:09 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Ranbaxy Gets USFDA Approval For Doxycycline Tablets
Ranbaxy Laboratories Ltd has received approval from USFDA for manufacturing and marketing Doxycycline Tablets in the US market.

The company informed the Bombay Stock Exchange that it got the approval for marketing the antibiotic in strengths of 50mg, 75mg and 100mg.

Doxycycline is indicated for a variety of infections caused by susceptible strains or micro-organisms including respiratory tract and urinary tract infections, skin and skin structure infections, it added.

The USFDA's office of Generic Drugs, has determined the company's formulations to be bioequivalent and having the same therapeutic effect as that of the branded drug Adoxa, marketed by Bioglan Pharmaceutical Co, Ranbaxy added.

Source:PTI News

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Q Fever 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...